Federal Register / Vol. 61, No. 95 / Wednesday, May 15, 1996 / Notices 24513

Notice of Lodging of Consent Order

Modification Pursuant to the Clean Air

Act

In accordance with Departmental

policy at 28 CFR § 50.7, notice is hereby

given that on April 30, 1996 a proposed

Second Consent Order Modification in

United States v. New Boston Coke

Corporation, Civil Action No. C–1–84–

1427 was lodged with the United States

District Court for the Southern District

of Ohio, Western Division. This Second

Consent Order Modification represents

settlement of claims by the United

States against the New Boston Coke

Corporation (‘‘New Boston’’) for

violations of the Clean Air Act, 42

U.S.C. 7401, and certain terms and

conditions of a Consent Order

Modification entered on September 25,

1993.

Under this settlement, New Boston

will implement and complete a program

for construction of a wastewater

treatment system to treat all direct

contact process wastewaters from its

coke recovery by-product plant, with

the treated wastewaters to be discharged

to the Ohio River pursuant to a modified

National Pollution System Discharge

Elimination System (‘‘NPDES’’) permit.

New Boston shall then achieve

compliance with certain limitations for

total dissolved solids in its quench

water by using only river water or noncontact process cooling water as

makeup water in its quenching

operations.

New Boston shall also comply with

certain emission limits in connection

with activities at its coke battery. In

addition, New Boston will pay an

aggregate civil penalty of $295,000.

Stipulated penalties may be imposed in

the event New Boston does not comply

with the requirements of the Second

Consent Order Modification.

The Department of Justice will receive

comments relating to the proposed

Second Consent Order Modification for

a period of thirty (30) days from the date

of this publication. Comments should be

addressed to the Assistant Attorney

General of the Environment and Natural

Resources Division, Department of

Justice, Washington, D.C. 20530, and

should refer to United States v. New

Boston Coke Corporation, D.J. # 90–5–2–

1–710B.

The proposed Second Consent Order

Modification may be examined at the

Office of the United States Attorney,

Southern District of Ohio, 220 U.S. Post

Office and Courthouse, 100 East Fifth

Street, Cincinnati, Ohio 45202, and at

U.S. EPA Region 5, Office of Regional

Counsel, 200 West Adams, Chicago,

Illinois 60604, and at the Consent

Decree Library, 1120 G Street, N.W., 4th

Floor, Washington, D.C. 20005, (202)

624–0892. A copy of the proposed

Second Consent Order Modification

may be obtained in person or by mail

from the Consent Decree Library. In

requesting a copy, please enclose a

check in the amount of $6.75 (25 cents

per page reproduction cost) payable to

the Consent Decree Library.

Joel M. Gross,

Chief, Environmental Enforcement Section,

Environment and Natural Resources Division.

[FR Doc. 96–12111 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Notice of Lodging of Consent Decree

Pursuant to the Clean Air Act

In accordance with Departmental

policy, 28 CFR § 50.7, 38 FR 19029,

notice is hereby given that on April 26,

1996, a proposed Consent Decree in

United States v. Raymond G. Regis, Paul

Wasson, and Wasson and Regis, a

Partnership, Civil Action No. 94–CV–

0319C(F), was lodged with the United

States District Court for the Western

District of New York resolving the

matters alleged in the United States’

complaint filed on April 28, 1994. The

proposed Consent Decree represents a

settlement of the United States’ claims

against Raymond G. Regis, Paul Wasson,

and Wasson and Regis, a Partnership

(‘‘Defendants’’) under the Safe Drinking

Water Act for Defendants’ violations of

the Safe Drinking Water Act by failing

to comply with the Underground

Injection Control (‘‘UIC’’) regulations for

Class II injection wells for the secondary

recovery of oil, 40 CFR Part 144.28,

promulgated under sections 300h and

300h–1 of the Safe Drinking Water Act,

42 U.S.C. 1421 and 1422, and for failure

to comply with the terms of a final

administrative order issued pursuant to

section 300h-2(c), 42 U.S.C. 1423(c),

requiring compliance with the Safe

Drinking Water Act UIC program.

Under the proposed Consent Decree

the Defendants shall comply with the

UIC regulations, including the

implementing regulations pertaining to

Class II Injection Wells at 40 CFR 144.22

and 144.28, and the Safe Drinking Water

Act. Under the consent decree,

Defendants are also required to submit

a plugging and abandonment schedule

(the ‘‘Schedule’’) for the fifteen wells at

the Stillman facility in Bolivar, New

York, within thirty days from the date

of lodging, which provides for the

proper plugging and abandonment of at

least three wells per year commencing

no later than calendar year 1996 and to

properly plug and abandon the fifteen

secondary, enhanced recovery injection

wells at the Stillman facility pursuant to

the Schedule and a previously

submitted and approved plugging and

abandonment plan (the ‘‘Plan’’).

The Department of Justice will

receive, for thirty (30) days from the

date of publication of this notice,

written comments relating to the

Consent Decree. Comments should be

addressed to the Assistant Attorney

General, Environment and Natural

Resources Division, U.S. Department of

Justice, Washington, D.C. 20530 and

should refer to United States v.

Raymond G. Regis, Paul Wasson, and

Wasson and Regis, a Partnership, D.O.J.

Ref. No. 90–5–1–1–3937.

The proposed Consent Decree may be

examined at the Office of the United

States Attorney for the Western District

of New York located at 68 Court Street,

Buffalo, New York 14202; at the Region

II Office of the Environmental

Protection Agency located at 290

Broadway, New York, New York 10007;

and at the Consent Decree Library, 1120

G Street, N.W., 4th Floor Washington,

D.C., 20005, (202)–624–0892. A copy of

the proposed Consent Decree may be

obtained in person or by mail from the

Consent Decree Library, 1120 G Street,

N.W., 4th Floor, Washington, D.C.,

20005. In requesting a copy, please

enclose a check in the amount of $15.50

(25 cents per page reproduction charge)

payable to the Consent Decree Library.

Joel M. Gross,

Chief, Environmental Enforcement Section,

Environment and Natural Resources Division.

[FR Doc. 96–12113 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Antitrust Division

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Advanced Process

Control Framework Initiative Program

Notice is hereby given that, on April

15, 1996, pursuant to § 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), the Advanced

Process Control Framework Initiative

Program (‘‘APCFIP’’) has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing (1) the identities

of the parties and (2) the nature and

objectives of the venture. The

notifications were filed for the purpose

of invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specified

circumstances. Pursuant to § 6(b) of the

Act, the identities of the parties are:

Honeywell Inc., Minneapolis, MN; and
24514 Federal Register / Vol. 61, No. 95 / Wednesday, May 15, 1996 / Notices

Advanced Micro Devices, Inc., Austin,

TX.

APCFIP’s area of planned activity is

development of advanced process

control required by the semiconductor

manufacturing industry.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–12110 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Consortium for Integrated

Intelligent Manufacturing, Planning

and Execution

Notice is hereby given that, on April

24, 1996, pursuant to § 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), the Consortium for

Integrated Intelligent Manufacturing,

Planning and Execution (‘‘CIIMPLEX’’)

has filed written notifications

simultaneously with the Attorney

General and the Federal Trade

Commission disclosing (1) the identities

of the parties and (2) the nature and

objectives of the venture. The

notifications were filed for the purpose

of invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specific

circumstances. Pursuant to § 6(b) of the

Act, the identities of the parties are:

International Business Machines

(‘‘IBM’’) Corporation, Charlotte, NC;

Berclain U.S.A., Schaumberg, IL;

Ingersoll Rand, Woodcliff Lake, NJ; J.D.

Edwards, Denver, CO; and QUD Inc.,

Mt. Laurel, NJ.

The CIIMPLEX Consortium’s area of

planned activity is the development of

open industry software protocols that

will integrate manufacturing, planning

and execution computing environments

across the U.S. manufacturing base.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–12108 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Antitrust Division

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—the Frame Relay Forum

Notice is hereby given that, on April

29, 1996, pursuant to § 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), the Frame Relay

Forum (‘‘Forum’’), has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing changes in its

membership. The notifications were

filed for the purpose of invoking the

Act’s provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the changes are as follows:

Cellstream Networks, Inc., Sarasota, FL;

Comsat Corporation, Clarksburg, MD;

Digital Equipment Corporation, Berks,

UNITED KINGDOM; Hekemian

Laboratories, Inc., Rockville, MD; and

InComA, Ltd, Moscow RUSSIA; have

been added as members to the venture.

Nortel DASA, Friedrichs Hafem,

GERMANY has been added as an

affiliate member. Loral Data Systems,

Sarasota, FL; and Defense Research

Agency, Malvern, Worcestershire,

UNITED KINGDOM have been dropped

as members of the venture.

On April 10, 1992, the Forum filed its

original notification pursuant to § 6(b) of

the Act. The Department of Justice

published a notice in the Federal

Register pursuant to § 6(b) of the Act on

July 2, 1992 (57 FR 29537). The last

notification was filed on December 27,

1995. A notice was published in the

Federal Register on February 20, 1996

(61 FR 6389).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–12109 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Antitrust Division

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; the ATM Forum

Notice is hereby given that, on

February 2, 1996, pursuant to § 6(a) of

the National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), the ATM Forum

(‘‘Forum’’) has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing changes in its

membership. The notifications were

filed for the purpose of extending the

Act’s provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the changes are as follows:

ABB, HAFO, Jarfalla, SWEDEN; Anixter,

Inc., Skokie, IL; Anritsu Wiltron, AtsugiShi, Kanagawa, JAPAN; Belgacom,

Brussels, BELGIUM; Diamond Lane

Communications, Petaluma, CA; GN

Nettest, Markham, Ontario, CANADA;

Incite, Dallas, TX; Integrated Systems

Technology, Lanham, MD; LittonFibercom, Roanoke, VA; Molex, Lisle,

IL; Scope Communications, Northboro,

MA; Southern New England Telephone,

North Haven, CT; Super Highway

Company, New York, NY; US Robotics,

Westborough, MA; and Wandel &

Goltermann, Eningen, GERMANY have

been added to the venture. Telenex has

changed its name to General Signal

Networks. Chipcom has withdrawn

from the venture.

On April 19, 1993, the Forum filed its

original notification pursuant to section

6(b) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant section 6(b) of the Act

on June 2, 1993 (58 FR 45532). The last

notification was filed on August 8, 1995.

A notice was published in the Federal

Register on March 12, 1996 (61 FR

10011).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–12107 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated February 2, 1996, and

published in the Federal Register on

February 13, 1996, (61 FR 5570), Isotec

Inc., 3858 Benner Road, Miamisburg,

Ohio 45342, made application to the

Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Cathinone (1235) ........................ I

Methcathinone (1237) ................. I

N-Ethylamphetamine (1475) ....... I

N,N-Dimethylamphetamine

(1480) ...................................... I

Aminorex (1585) ......................... I

Methaqualone (2565) .................. I

Lysergic acid diethylamide

(7315) ...................................... I

Tetrahydrocannabinols (7370) .... I

Mescaline (7381) ........................ I

2,5-Dimethoxyamphetamine

(7396) ...................................... I

3,4-Methylenedioxyamphetamine

(7400) ...................................... I

3,4-Methylenedioxy-Nethylamphetamine (7404) ....... I

3,4-Methylenedioxymethamphetamine (7405) .................... I

Psilocybin (7437) ........................ I

Psilocyn (7438) ........................... I

N-Ethyl-1-phenylcyclohexylamine

(7455) ...................................... I

Dihydromorphine (9145) ............. I

Normorphine (9313) .................... I

Acetylmethadol (9601) ................ I

Alphacetylmethadol Except

Levo-Alphacetylmethadol

(9603) ...................................... I

Normethadone (9635) ................. I

3-Methylfentanyl (9813) .............. I